Form 8-K - Current report:
SEC Accession No. 0001104659-25-009279
Filing Date
2025-02-05
Accepted
2025-02-04 21:18:31
Documents
25
Period of Report
2025-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255497d1_8k.htm   iXBRL 8-K 33225
2 EXHIBIT 1.1 tm255497d1_ex1-1.htm EX-1.1 415410
3 EXHIBIT 4.1 tm255497d1_ex4-1.htm EX-4.1 105215
4 EXHIBIT 4.2 tm255497d1_ex4-2.htm EX-4.2 103139
5 EXHIBIT 5.1 tm255497d1_ex5-1.htm EX-5.1 14743
6 EXHIBIT 99.1 tm255497d1_ex99-1.htm EX-99.1 9811
7 EXHIBIT 99.2 tm255497d1_ex99-2.htm EX-99.2 9531
8 EXHIBIT 99.3 tm255497d1_ex99-3.htm EX-99.3 9445
12 GRAPHIC tm255497d1_ex5-1img001.jpg GRAPHIC 4892
13 GRAPHIC tm255497d1_ex5-1img002.jpg GRAPHIC 2520
14 GRAPHIC tm255497d1_ex99-1img01.jpg GRAPHIC 4669
15 GRAPHIC tm255497d1_ex99-2img01.jpg GRAPHIC 4669
16 GRAPHIC tm255497d1_ex99-3img01.jpg GRAPHIC 4669
  Complete submission text file 0001104659-25-009279.txt   1071845

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA anvs-20250203.xsd EX-101.SCH 3021
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anvs-20250203_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anvs-20250203_pre.xml EX-101.PRE 22363
27 EXTRACTED XBRL INSTANCE DOCUMENT tm255497d1_8k_htm.xml XML 3785
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 25590495
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)